Serum autotaxin is not a useful biomarker for ovarian cancer

Lipids

Volumn 47, Issue 9, 2012, Pages 927-930

  Nakamura, Kazuhiro ^a   Igarashi, Koji ^b   Ohkawa, Ryunosuke ^c   Yokota, Hiromitsu ^c   Masuda, Akiko ^a,c   Nakagawa, Shunsuke ^a   Yano, Tetsu ^a   Ikeda, Hitoshi ^a,c   Aoki, Junken ^d,e   Yatomi, Yutaka ^a,c  

^a UNIVERSITY OF TOKYO   (Japan)

^b AIA Research Group   (Japan)

^c UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^d TOHOKU UNIVERSITY   (Japan)

^e JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Autotaxin; Clinical laboratory testing; Immunoenzymetric assay; Lysophosphatidic acids; Ovarian cancer; Tumor marker

Indexed keywords

AUTOTAXIN; BIOLOGICAL MARKER; LYSOPHOSPHATIDIC ACID;

ARTICLE; CANCER PATIENT; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN TISSUE; LABORATORY TEST; MAJOR CLINICAL STUDY; OVARY CANCER; PROTEIN BLOOD LEVEL;

ADULT; FEMALE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; PHOSPHORIC DIESTER HYDROLASES; REFERENCE STANDARDS; TUMOR MARKERS, BIOLOGICAL;

EID: 84866656014     PISSN: 00244201     EISSN: 15589307     Source Type: Journal    
DOI: 10.1007/s11745-012-3691-0     Document Type: Article

References (18)

1. Moolenaar WH, van Meeteren LA, Giepmans BN (2004) The ins and outs of lysophosphatidic acid signaling. BioEssays 26: 870-881
2. Lee CW, Rivera R, Gardell S, Dubin AE, Chun J (2006) GPR92 as a new G12/13- and Gq-coupled lysophosphatidic acid receptor that increases cAMP, LPA5. J Biol Chem 281:23589-23597
3. Yanagida K, Masago K, Nakanishi H, Kihara Y, Hamano F, Tajima Y, Taguchi R, Shimizu T, Ishii S (2009) Identification and characterization of a novel lysophosphatidic acid receptor, p2y5/LPA6. J Biol Chem 284:17731-17741
4. Umezu-Goto M, Kishi Y, Taira A, Hama K, Dohmae N, Takio K, Yamori T, Mills GB, Inoue K, Aoki J, Arai H (2002) Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J Cell Biol 158:227-233
5. Xu Y, Fang XJ, Casey G, Mills GB (1995) Lysophospholipids activate ovarian and breast cancer cells. Biochem J 309(Pt 3): 933-940
6. Jeong KJ, Park SY, Cho KH, Sohn JS, Lee J, Kim YK, Kang J, Park CG, Han JW, Lee HY (2012) The Rho/ROCK pathway for lysophosphatidic acid-induced proteolytic enzyme expression and ovarian cancer cell invasion. Oncogene (in press)
7. Ptaszynska MM, Pendrak ML, Bandle RW, Stracke ML, Roberts DD (2008) Positive feedback between vascular endothelial growth factor-A and autotaxin in ovarian cancer cells. Mol Cancer Res 6:352-363
8. Vidot S, Witham J, Agarwal R, Greenhough S, Bamrah HS, Tigyi GJ, Kaye SB, Richardson A (2010) Autotaxin delays apoptosis induced by carboplatin in ovarian cancer cells. Cell Signal 22:926-935
9. Nakamura K, Takeuchi T, Ohkawa R, Okubo S, Yokota H, Tozuka M, Aoki J, Arai H, Ikeda H, Ohshima N, Kitamura T, Yatomi Y (2007) Serum lysophospholipase D/autotaxin may be a new nutritional assessment marker: study on prostate cancer patients. Ann Clin Biochem 44:549-556
10. Masuda A, Nakamura K, Izutsu K, Igarashi K, Ohkawa R, Jona M, Higashi K, Yokota H, Okudaira S, Kishimoto T, Watanabe T, Koike Y, Ikeda H, Kozai Y, Kurokawa M, Aoki J, Yatomi Y (2008) Serum autotaxin measurement in haematological malignancies: a promising marker for follicular lymphoma. Br J Haematol 143:60-70
11. Xu Y, Shen Z, Wiper DW, Wu M, Morton RE, Elson P, Kennedy AW, Belinson J, Markman M, Casey G (1998) Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers. JAMA 280:719-723
12. Baker DL, Morrison P, Miller B, Riely CA, Tolley B, Westermann AM, Bonfrer JM, Bais E, Moolenaar WH, Tigyi G (2002) Plasma lysophosphatidic acid concentration and ovarian cancer. JAMA 287:3081-3082
13. Nakamura K, Ohkawa R, Okubo S, Tozuka M, Okada M, Aoki S, Aoki J, Arai H, Ikeda H, Yatomi Y (2007) Measurement of lysophospholipase D/autotaxin activity in human serum samples. Clin Biochem 40:274-277
14. Nakamura K, Igarashi K, Ide K, Ohkawa R, Okubo S, Yokota H, Masuda A, Oshima N, Takeuchi T, Nangaku M, Okudaira S, Arai H, Ikeda H, Aoki J, Yatomi Y (2008) Validation of an autotaxin enzyme immunoassay in human serum samples and its application to hypoalbuminemia differentiation. Clin Chim Acta 388:51-58
15. Watanabe N, Ikeda H, Nakamura K, Ohkawa R, Kume Y, Aoki J, Hama K, Okudaira S, Tanaka M, Tomiya T, Yanase M, Tejima K, Nishikawa T, Arai M, Arai H, Omata M, Fujiwara K, Yatomi Y (2007) Both plasma lysophosphatidic acid and serum autotaxin levels are increased in chronic hepatitis C. J Clin Gastroenterol 41:616-623
16. Hosogaya S, Yatomi Y, Nakamura K, Ohkawa R, Okubo S, Yokota H, Ohta M, Yamazaki H, Koike T, Ozaki Y (2008) Measurement of plasma lysophosphatidic acid concentration in healthy subjects: strong correlation with lysophospholipase D activity. Ann Clin Biochem 45:364-368
17. Bast RC Jr, Klug TL, St John E, Jenison E, Niloff JM, Lazarus H, Berkowitz RS, Leavitt T, Griffiths CT, Parker L, Zurawski VR Jr, Knapp RC (1983) A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med 309:883-887
18. Nakai Y, Ikeda H, Nakamura K, Kume Y, Fujishiro M, Sasahira N, Hirano K, Isayama H, Tada M, Kawabe T, Komatsu Y, Omata M, Aoki J, Koike K, Yatomi Y (2011) Specific increase in serum autotaxin activity in patients with pancreatic cancer. Clin Biochem 44:576-581